CG Oncology (CGON) PT Raised to $82 at Truist Securities
Truist Securities analyst Greg Renza raised the price target on CG Oncology (NASDAQ: CGON) to $82.00 (from $77.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
